Single‐center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Single‐center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia

Published:2020-07-31 Issue:10 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Winters Amanda C.¹^ORCID,Maloney Kelly W.¹,Treece Amy L.²,Gore Lia¹,Franklin Anna K.¹

Affiliation:

1. Center for Cancer and Blood Disorders Children's Hospital Colorado Aurora Colorado

2. Department of Pathology Children's Hospital Colorado Aurora Colorado

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28398

Reference31 articles.

1. New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics

2. Pediatric AML: From Biology to Clinical Management

3. Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia

4. Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

5. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder;Life Science Alliance;2024-08-27

2. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia;Pediatric Blood & Cancer;2024-08-16

3. Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients;British Journal of Haematology;2024-07-31

4. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

5. Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience;HemaSphere;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3